Soltis Investment Advisors LLC Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Soltis Investment Advisors LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 519 shares of the medical equipment provider’s stock after purchasing an additional 58 shares during the quarter. Soltis Investment Advisors LLC’s holdings in Intuitive Surgical were worth $255,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ISRG. ORG Partners LLC boosted its stake in Intuitive Surgical by 3,411.1% during the 2nd quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider’s stock valued at $138,000 after acquiring an additional 307 shares during the last quarter. Fiduciary Financial Group LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $394,000. Valley National Advisers Inc. grew its stake in Intuitive Surgical by 29.3% in the second quarter. Valley National Advisers Inc. now owns 622 shares of the medical equipment provider’s stock worth $276,000 after purchasing an additional 141 shares in the last quarter. Miracle Mile Advisors LLC increased its holdings in Intuitive Surgical by 13.4% in the second quarter. Miracle Mile Advisors LLC now owns 1,676 shares of the medical equipment provider’s stock valued at $746,000 after buying an additional 198 shares during the last quarter. Finally, Pure Financial Advisors LLC raised its stake in Intuitive Surgical by 2.4% during the second quarter. Pure Financial Advisors LLC now owns 1,506 shares of the medical equipment provider’s stock valued at $670,000 after buying an additional 35 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on ISRG shares. Wells Fargo & Company lifted their target price on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Citigroup raised their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $550.28.

Intuitive Surgical Stock Up 0.2 %

ISRG opened at $544.72 on Friday. The firm has a market capitalization of $194.02 billion, a P/E ratio of 87.58, a PEG ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $320.22 and a 12-month high of $556.23. The stock has a fifty day moving average of $519.37 and a 200-day moving average of $477.06.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.